Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

Related Citations for PubMed (Select 21723283)

1.

Epigenetic regulation of microRNA-375 and its role in melanoma development in humans.

Mazar J, DeBlasio D, Govindarajan SS, Zhang S, Perera RJ.

FEBS Lett. 2011 Aug 4;585(15):2467-76. doi: 10.1016/j.febslet.2011.06.025. Epub 2011 Jun 26.

2.

Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma.

Mazar J, Khaitan D, DeBlasio D, Zhong C, Govindarajan SS, Kopanathi S, Zhang S, Ray A, Perera RJ.

PLoS One. 2011;6(9):e24922. doi: 10.1371/journal.pone.0024922. Epub 2011 Sep 19.

3.

MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.

Chen X, He D, Dong XD, Dong F, Wang J, Wang L, Tang J, Hu DN, Yan D, Tu L.

Invest Ophthalmol Vis Sci. 2013 Mar 1;54(3):2248-56. doi: 10.1167/iovs.12-10977.

4.

Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.

Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshikawa K, Kimura T, Kudo T, Harada E, Sugai T, Takamaru H, Niinuma T, Maruyama R, Yamamoto H, Tokino T, Imai K, Toyota M, Shinomura Y.

Carcinogenesis. 2010 Dec;31(12):2066-73. doi: 10.1093/carcin/bgq203. Epub 2010 Oct 5.

5.

Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T.

Cancer Res. 2008 Jun 1;68(11):4123-32. doi: 10.1158/0008-5472.CAN-08-0325.

6.

Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.

Liu S, Ren S, Howell P, Fodstad O, Riker AI.

Pigment Cell Melanoma Res. 2008 Oct;21(5):545-58. doi: 10.1111/j.1755-148X.2008.00484.x. Epub 2007 Jun 28.

PMID:
18627528
7.

MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.

Yan D, Zhou X, Chen X, Hu DN, Dong XD, Wang J, Lu F, Tu L, Qu J.

Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1559-65. doi: 10.1167/iovs.08-2681. Epub 2008 Nov 21.

8.

Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.

Nguyen T, Kuo C, Nicholl MB, Sim MS, Turner RR, Morton DL, Hoon DS.

Epigenetics. 2011 Mar;6(3):388-94. Epub 2011 Mar 1.

9.

Signatures of microRNAs and selected microRNA target genes in human melanoma.

Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A, Vallar L, Nashan D, Behrmann I, Kreis S.

Cancer Res. 2010 May 15;70(10):4163-73. doi: 10.1158/0008-5472.CAN-09-4512. Epub 2010 May 4.

10.

MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.

Mueller DW, Bosserhoff AK.

Int J Cancer. 2011 Sep 1;129(5):1064-74. doi: 10.1002/ijc.25768. Epub 2011 Feb 11.

PMID:
21077158
11.

MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.

Satzger I, Mattern A, Kuettler U, Weinspach D, Voelker B, Kapp A, Gutzmer R.

Int J Cancer. 2010 Jun 1;126(11):2553-62. doi: 10.1002/ijc.24960.

PMID:
19830692
12.

Epigenetic regulation of microRNA expression in colorectal cancer.

Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F, Garcia-Foncillas J.

Int J Cancer. 2009 Dec 1;125(11):2737-43. doi: 10.1002/ijc.24638.

PMID:
19521961
13.

A microRNA DNA methylation signature for human cancer metastasis.

Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez-Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, Gallagher WM, Eccles SA, Croce CM, Esteller M.

Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13556-61. doi: 10.1073/pnas.0803055105. Epub 2008 Sep 3.

14.

Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.

Spugnardi M, Tommasi S, Dammann R, Pfeifer GP, Hoon DS.

Cancer Res. 2003 Apr 1;63(7):1639-43.

15.

Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment.

Costa FF, Seftor EA, Bischof JM, Kirschmann DA, Strizzi L, Arndt K, Bonaldo Mde F, Soares MB, Hendrix MJ.

Epigenomics. 2009 Dec;1(2):387-98. doi: 10.2217/epi.09.25.

16.

Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.

Levati L, Alvino E, Pagani E, Arcelli D, Caporaso P, Bondanza S, Di Leva G, Ferracin M, Volinia S, Bonmassar E, Croce CM, D'Atri S.

Int J Oncol. 2009 Aug;35(2):393-400.

PMID:
19578755
17.

Epigenetic inactivation of RASSF1a in uveal melanoma.

Maat W, van der Velden PA, Out-Luiting C, Plug M, Dirks-Mulder A, Jager MJ, Gruis NA.

Invest Ophthalmol Vis Sci. 2007 Feb;48(2):486-90.

18.

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.

Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J.

Carcinogenesis. 2010 May;31(5):766-76. doi: 10.1093/carcin/bgp250. Epub 2009 Oct 20.

19.

miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.

Rauhala HE, Jalava SE, Isotalo J, Bracken H, Lehmusvaara S, Tammela TL, Oja H, Visakorpi T.

Int J Cancer. 2010 Sep 1;127(6):1363-72. doi: 10.1002/ijc.25162.

PMID:
20073067
20.

Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.

Boyle GM, Woods SL, Bonazzi VF, Stark MS, Hacker E, Aoude LG, Dutton-Regester K, Cook AL, Sturm RA, Hayward NK.

Pigment Cell Melanoma Res. 2011 Jun;24(3):525-37. doi: 10.1111/j.1755-148X.2011.00849.x. Epub 2011 Apr 7.

PMID:
21435193
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk